Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
PCR
Roche launches diagnostic test for 12 respiratory viruses
By
LabPulse.com staff writers
Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.
September 26, 2024
CDC adds commercial lab contracts for infectious disease, bird flu testing
By
Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Seegene, Springer Nature launch PCR innovation program
By
LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
CDC prioritizes mpox specimens for testing laboratories
By
LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Seegene develops two RUO mpox assays
By
LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
FDA greenlights BioMérieux's mini respiratory, sore throat panel for POC testing
By
LabPulse.com staff writers
BioMérieux received special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel Mini respiratory viral and bacterial testing device designed for point-of-care (POC) testing.
June 28, 2024
Co-Diagnostics submits 510(k) applications for platform, OTC COVID-19 test
By
LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics submitted its first U.S. Food and Drug Administration application for 510(k) clearance for its Co-Dx PCR Pro instrument, along with the Co-Dx PCR COVID-19 Test for over-the-counter (OTC) use.
June 17, 2024
Qiagen gets FDA clearance for respiratory syndromic testing panel
By
LabPulse.com staff writers
Qiagen announced that it has received U.S. Food and Drug Administration (FDA) clearance for its QIAstat-Dx respiratory syndromic testing panel for clinical use.
May 14, 2024
Qiagen partners with FBI on forensics assay
By
LabPulse.com staff writers
Qiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.
May 8, 2024
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By
LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Thermo Fisher launches new instrument, kit for respiratory testing
By
LabPulse.com staff writers
Thermo Fisher Scientific has launched a nucleic acid purification instrument and kit for automated viral and bacterial respiratory testing.
December 11, 2023
Researchers develop technique for onsite detection of SARS-CoV-2
By
LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Page 1 of 23
Next Page